<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996148</url>
  </required_header>
  <id_info>
    <org_study_id>17-108</org_study_id>
    <nct_id>NCT03996148</nct_id>
  </id_info>
  <brief_title>Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques</brief_title>
  <official_title>Time to Post-Anesthesia Neurological Evaluation and Hemodynamic Stability in Carotid Endarterectomy Comparing Three General Anesthetic Techniques Targeted to a Preset Bispectral Index Value: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cooper Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cooper Health System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study is to analyze the differences in time to first
      postoperative neurological examination (cranial nerve XII - tongue movement, movement of
      extremities) and intraoperative hemodynamic stability with three different general anesthetic
      techniques that are used for carotid endarterectomy. Carotid endarterectomy surgery removes
      the plaque and stenosis but has a 1-3% risk of periprocedural stroke or death. The ability to
      detect neurological abnormalities early after surgery is vital in this patient population to
      facilitate timely additional diagnostics or interventions if a potential stroke is detected.
      Anesthetic techniques that facilitate an earlier reliable neurological exam will thus greatly
      benefit this surgical patient population. The primary objective of this pilot study is to
      determine the time difference from end of surgery to first neurologic exam between three
      commonly used anesthetic methods for carotid endareterectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 29, 2017</start_date>
  <completion_date type="Actual">September 19, 2018</completion_date>
  <primary_completion_date type="Actual">September 19, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first neurological exam</measure>
    <time_frame>Time (minutes) to first neurological exam immediately after emergence from general anesthesia.</time_frame>
    <description>Time to first neurological exam after emergence from general anesthesia</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>Remifentanil, Propofol, and Desflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study group A: no midazolam given; maintenance drugs started immediately after induction and airway is secured.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remifentanil, Dexmedetomidine, and Desflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study group B: no midazolam given; maintenance drugs started immediately after induction and airway is secured.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remifentanil and Desflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study group C (control group): no midazolam given; maintenance drugs started immediately after induction and airway is secured.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil, Propofol, and Desflurane</intervention_name>
    <description>Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Propofol - titratable; initial starting dose 75 mcg/kg/min Desflurane 0.5 MAC</description>
    <arm_group_label>Remifentanil, Propofol, and Desflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil, Dexmedetomidine, and Desflurane</intervention_name>
    <description>Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Dexmedetomidine - titratable; initial starting dose 0.5 mcg/kg/hr Desflurane 0.5 MAC</description>
    <arm_group_label>Remifentanil, Dexmedetomidine, and Desflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil and Desflurane</intervention_name>
    <description>Remifentanil - titratable; initial starting dose 0.05 mcg/kg/min Desflurane - titratable</description>
    <arm_group_label>Remifentanil and Desflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years of age and older

          2. Having carotid endarterectomy surgery

          3. Able to undergo a preoperative neurological exam

        Exclusion Criteria:

          1. Pregnant patients

          2. Prisoners

          3. Patients with dementia or reduced mental status acute or chronic

          4. Known brain tumor or head trauma

          5. Known severe, uncorrected coronary artery disease (CAD)

          6. Ejection fraction (EF) less than 15%

          7. Patients with intraaortic ballon pump (IABP) or other mechanical circulatory assist
             device

          8. Patients with severe chronic obstructive pulmonary disease (COPD)

          9. Combined surgical procedures (CABG and CAD)

         10. Patients with uncontrolled or severe anxiety requiring benzodiazepine administration

         11. Patients with history of difficult airway

         12. Sedation other than propofol, dexmedetomidine or volatile anesthetic agent (VAA) is
             needed for patient (i.e. ketamine in patients with history of neuropathic pain)

         13. Intubated or unconscious patients

         14. Patients on methadone or fentanyl patch

         15. Patients with known unusual or extreme anesthetic requirements

         16. Patients who would require an unusual amount of narcotic to control pain

         17. Patients having endarterectomy wherein surgeon requests local-regional anesthesia only

         18. Patients with known history of prolonged emergence from anesthesia

         19. Morbidly obese patients (BMI &gt;40)

         20. Patients with scalp or forehead defects that prohibit application of BIS monitor strip
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 29, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2019</study_first_posted>
  <last_update_submitted>June 21, 2019</last_update_submitted>
  <last_update_submitted_qc>June 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cooper Health System</investigator_affiliation>
    <investigator_full_name>Rhea Temmermand</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

